Literature DB >> 2760483

Impaired clearance of aerosolized Legionella pneumophila in corticosteroid-treated rats: a model of Legionnaires' disease in the compromised host.

S J Skerrett1, R A Schmidt, T R Martin.   

Abstract

To develop a model of legionnaires' disease in a host with defective cell-mediated immunity, rats were treated with subcutaneous cortisone acetate and exposed to aerosolized Legionella pneumophila. Bacterial clearance, histopathology, cell recovery by bronchoalveolar lavage, serology, and splenocyte blastogenesis to heat-killed L. pneumophila were studied in cortisone-treated rats and normal controls. Corticosteroid administration resulted in a dosage-related defect in the clearance of L. pneumophila. Cortisone-treated animals had a diffuse, progressive pneumonitis, but the influx of neutrophils to the lung, the serum antibody response, and the sensitization of splenocytes to L. pneumophila were not impaired by corticosteroids. The marked lymphocyte depletion observed in cortisone-treated animals may have contributed to defective expression of cell-mediated immunity. This model may be useful in further studies of the pathogenesis and treatment of legionellosis in the compromised host.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760483     DOI: 10.1093/infdis/160.2.261

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Bactericidal effects of ticarcillin-clavulanic acid against Legionella pneumophila pneumonia in immunocompromised weanling rats.

Authors:  G M Smith; K H Abbott; M J Wilkinson; A S Beale; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  Roles for tumor necrosis factor alpha and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila.

Authors:  S J Skerrett; T R Martin
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

3.  Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aureus infection.

Authors:  Y Ji; A Marra; M Rosenberg; G Woodnutt
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

4.  Genomic stability of Legionella pneumophila isolates recovered from two cardiac transplant patients with nosocomial Legionnaires' disease.

Authors:  T J Marrie; W M Johnson; S D Tyler; G S Bezanson; S Burbridge
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

5.  Environmental mimics and the Lvh type IVA secretion system contribute to virulence-related phenotypes of Legionella pneumophila.

Authors:  Purnima Bandyopadhyay; Shuqing Liu; Carolina B Gabbai; Zeah Venitelli; Howard M Steinman
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

6.  Effector mechanisms responsible for gamma interferon-mediated host resistance to Legionella pneumophila lung infection: the role of endogenous nitric oxide differs in susceptible and resistant murine hosts.

Authors:  L Heath; C Chrisp; G Huffnagle; M LeGendre; Y Osawa; M Hurley; C Engleberg; J Fantone; J Brieland
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

7.  Replicative Legionella pneumophila lung infection in intratracheally inoculated A/J mice. A murine model of human Legionnaires' disease.

Authors:  J Brieland; P Freeman; R Kunkel; C Chrisp; M Hurley; J Fantone; C Engleberg
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.